How to Control Impurities during API drug manufacturing

by | Feb 19, 2018 | API Manufacturing, Impurities, Video

Dr. Rajesh Shukla, Vice President Research and Development at Seqens Talks about Controlling Impurities during API drug manufacturing.

Related posts:

From Glassware to Fixed Reactors in API Manufacturing
Ed Price talks cGMP Medical Grade Polymers
What CDMO Capacity Refers to and What to Look For
How to Stem the Flow of Tainted Generic Drugs and Product Recalls
Three Things to Know About API Development for Phase 2 Clinical Trials